Studies show these medications: Lower total cholesterol, LDL cholesterol, and triglyceride levels 10 Reduce small- and medium-sized LDL particles, which are particularly harmful 10 Promote cholesterol efflux from cells through increased ABCA1 expression 11 Liraglutide and taspoglutide demonstrate exceptional cholesterol-lowering effects, especially on total cholesterol and triglycerides 10
doi:10.1136/bmj-2023-076410 Almandoz JP, Wadden TA, Tewksbury C, et al
Diabetes 57: 2280-2287, 2008
Encapsulation of exenatide in poly-(D,L-lactide-co-glycolide) microspheres produced an investigational long-acting once-weekly formulation for type 2 diabetes
How much weight can I expect to lose
Development of an orally delivered GLP-1 receptor agonist through peptide engineering and drug delivery to treat chronic disease